# Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

> **NCT00000570** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Lung Diseases
- Respiratory Distress Syndrome

## Interventions

- **DRUG:** pulmonary surfactant

## Key facts

- **NCT ID:** NCT00000570
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1986-01
- **Primary completion:** —
- **Final completion:** 1990-06
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000570, "Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*